Drug intelligence / Profile preview

Yan Ning Syrup

Development stage: Unknown
Lead developer: Pharmaron
Administration: Oral

Overview

Yan Ning Syrup is a Traditional Chinese Medicine (TCM) formulation developed by Harbin Kanglong Pharmaceutical Co., Ltd. It is primarily indicated for the treatment of acute tonsillitis, specifically the "wind-heat invading throat" pattern in pediatric patients. The syrup is designed to clear heat, detoxify the body, and alleviate symptoms such as throat pain and swelling. As of 2025, it is undergoing Phase II clinical evaluation in China to assess its efficacy and safety in children aged 3 to 12 years compared to a placebo mimic.

Brand names: Yan Ning Syrup
Other names: Yan Ning Tang Jiang咽宁糖浆

Beyond the preview

Go deeper on Yan Ning Syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yan Ning Syrup.

Explore the full profile